| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Martin Michael Robert is a Chief Business Officer at Aurinia Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $4.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Chief Business Officer | Sell | 5,000 | $13.86 | $69,300.00 | -2.3% | +113.1% | -41.6% | |
| Jun 22, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Chief Business Officer | Sell | 5,000 | $13.76 | $68,800.00 | -2.3% | +49.3% | -20.4% |